Sweeteners and PCOS: What Each One Does to Insulin

Do Any Sweeteners Actually Raise Insulin?

Sucrose reliably produces a large glucose and insulin spike; the four non-nutritive and rare sweeteners covered here do not, at the doses tested. A crossover trial in 30 healthy men compared aspartame-, monk fruit-, stevia- and sucrose-sweetened beverages and found the sucrose drink produced large spikes in blood glucose and insulin within the first hour, while none of the three non-nutritive sweeteners did — total area under the curve for glucose and insulin over three hours did not differ significantly between the three non-sugar options. That is the baseline fact behind every sweetener claim on this page: at the doses studied, none of stevia, monk fruit, erythritol or allulose behaves like sugar metabolically. What differs between them is everything else — satiety, gut tolerance, and in one case, a cardiovascular signal worth taking seriously.

What Does Stevia Actually Do to Blood Sugar?

Stevia preloads significantly lowered postprandial glucose compared with sucrose in a controlled trial, not just theoretically. Researchers gave 19 lean and 12 obese adults preloads of stevia (290 kcal), aspartame (290 kcal) or sucrose (493 kcal) before lunch and dinner, and stevia significantly reduced postprandial glucose versus sucrose and reduced postprandial insulin versus both aspartame and sucrose. Despite the sucrose preload containing 203 more calories, participants did not eat more at subsequent meals when given stevia or aspartame instead — total daily intake still ran about 300 calories lower on the stevia and aspartame days, with no difference in reported hunger or fullness. Stevia’s glucose and insulin profile in this trial was essentially flat compared with real sugar, at a dose well within normal beverage-sweetening use.

Does Monk Fruit Do Anything Different From Stevia?

Monk fruit produced no measurable glucose or insulin spike in the same head-to-head beverage trial that tested it directly against stevia, aspartame and sucrose. In that 30-person crossover study, the monk fruit-sweetened beverage behaved like the other two non-nutritive sweeteners — no significant glucose or insulin excursion in the first hour, and no difference in total 3-hour AUC from stevia or aspartame. Mechanistically, monk fruit’s sweetness comes from mogrosides, compounds structurally unrelated to both sugar and stevia’s steviol glycosides, which is why it is often marketed as “the other” natural option — but on the glucose and insulin measures that matter for insulin resistance, the trial data puts it in the same practical category as stevia rather than as a meaningfully different choice.

What Is Erythritol’s Glycemic Index, and Why Does That Number Matter Less Than the Headlines Suggest?

Erythritol’s glycaemic index is 0 and its insulinaemic index is 2, against a glucose reference of 100 for both. A widely cited review of polyol sweeteners calculated these exact glycaemic and insulinaemic index values from the available human trial data, placing erythritol at the very bottom of the sugar-alcohol group — lower than xylitol (13, 11) and sorbitol (9, 11). Mechanistically, erythritol is almost entirely absorbed in the small intestine and excreted unchanged in urine rather than metabolised, which is both why it barely touches blood glucose and why it does not ferment in the colon the way some other sugar alcohols do, sidestepping the gas and bloating that a large dose of sorbitol or maltitol commonly causes.

Is the Erythritol Heart-Risk Study Something to Actually Worry About?

Yes, enough to know about it, and the honest caveat is that the study shows association, not a proven mechanism of harm in ordinary use. A 2023 study measuring plasma erythritol in patients undergoing cardiac risk assessment found the highest quartile of circulating erythritol carried an adjusted hazard ratio of 1.80 for major adverse cardiovascular events in a US validation cohort, and 2.21 in a European one, compared with the lowest quartile. The same study found erythritol increased platelet reactivity and thrombosis formation in lab and animal models, and a small pilot study in 8 healthy volunteers showed a single dose of erythritol raised plasma levels for more than 2 days, well above the levels linked to platelet effects in the earlier experiments. This is observational human data plus supporting mechanism, not a randomised trial proving erythritol causes heart attacks — but it is a large enough, specific enough signal that erythritol is no longer the “obviously safest” sugar alcohol by default, and someone with existing cardiovascular risk factors has a reasonable, evidence-based reason to choose a different sweetener from this list.

What Does Allulose Do That the Others Don’t?

Allulose measurably lowered the glucose rise from a meal across 8 randomised trials totalling 145 people, most using a 5-gram dose. A systematic review and meta-analysis pooling this data found that adding 5 or 10 grams of allulose alongside carbohydrate significantly reduced the area under the postprandial glucose curve compared with the same meal without it. That is a meaningfully different claim from the other three sweeteners on this page: stevia, monk fruit and erythritol are largely neutral on glucose because the body barely processes them at all, while allulose appears to actively blunt the glucose response to the carbohydrate eaten alongside it, not just avoid adding its own. All 8 trials were small (8 to 30 people per group) and run in healthy adults rather than in PCOS or diabetes populations specifically, so the effect size in an insulin-resistant person has not been directly measured — but the direction and consistency across 8 independent trials is a stronger signal than a single study would provide.

Which Sweetener Should You Actually Pick?

There is no single “best” sweetener across every situation — the right pick depends on what you’re optimising for, not a ranking with one winner. For someone specifically trying to blunt a glucose spike from a carbohydrate-containing food, allulose has the most direct supporting trial data, since it is the only one of the four shown to actively reduce the glucose response rather than simply avoid adding to it. For everyday beverage or recipe sweetening with the largest and most consistent evidence base, stevia and monk fruit both perform similarly and neither carries a cardiovascular signal. Erythritol remains reasonable for most people in ordinary amounts, but is the one sweetener on this list where a specific population — anyone with existing cardiovascular risk — has real evidence-based reason to choose differently.

Do These Behave the Same Way in Cooking as They Do in a Drink?

Not quite — sweetness intensity and heat stability differ enough between these four that a one-for-one sugar swap rarely works without adjustment. Stevia extract is roughly 200–400 times sweeter than sugar by weight, and monk fruit extract is typically 100–250 times sweeter, so both are usually sold pre-blended with a bulking agent like erythritol specifically so a recipe can use a cup-for-cup measurement. Erythritol and allulose are both close enough to sugar’s actual sweetness and bulk — erythritol at roughly 70% as sweet, allulose at roughly 70% as sweet — that they behave more like sugar in baking, contributing browning and texture that stevia and monk fruit alone cannot. None of the trial data above was generated from baked or heated versions of these sweeteners, so glucose and insulin figures reflect drinking or eating them as-is, not necessarily after time in an oven.

Who Should Be More Careful With These Sweeteners?

People with a cardiovascular risk factor already present are the clearest “avoid this one” finding on this page, specifically for erythritol rather than the group as a whole. Sugar alcohols including erythritol can cause bloating, gas or a laxative effect in a meaningful minority of people at higher doses — typically above 20–30 grams in one sitting for the less-absorbed polyols, though erythritol itself is tolerated at higher doses than most because it is absorbed rather than fermented. None of the four sweeteners here has been tested specifically in a PCOS trial for glucose or insulin outcomes; every number above comes from general adult or healthy-volunteer populations, and the insulin-resistant PCOS phenotype is the one most likely to see any benefit translate, though that is inference rather than a PCOS-specific result. If a sweetener consistently triggers digestive symptoms, that is a reason to switch products, not a sign of a metabolic problem.

Is This Different Now That PCOS Is Called PMOS?

No. PCOS was renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026 by a global consensus process spanning more than 50 organisations, and none of the sweetener evidence above moved with the name change. This article uses PCOS because that is still the term most people search.

How Sweeteners Fit With the Rest of Sugar and Carbohydrate

None of the four sweeteners compared above are the traditional sugars often reached for as a “natural” swap in South Asian cooking — whether jaggery is actually a better choice than table sugar is answered directly here.

Swapping sucrose for a lower-impact sweetener addresses one narrow decision inside a much larger picture. How much sugar is actually too much covers the added-sugar question this article assumes as background, and how many carbs a day makes sense with PCOS covers the total carbohydrate picture a sweetener swap sits inside. If a starchy food rather than a sweetener is the actual question, potatoes and starchy vegetables covers the same glucose-and-insulin lens applied there. For a shelf-ready snack option built around several of these sweeteners already, the store-bought PCOS snack roundup names what is actually on the shelf.